Perception of the COVID-19 Pandemic Among Patients With Inflammatory Bowel Disease in the Time of Telemedicine: Cross-Sectional Questionnaire Study.
Adult
Anxiety
/ epidemiology
COVID-19
Coronavirus Infections
/ epidemiology
Cross-Sectional Studies
Delivery of Health Care
Disease Outbreaks
Female
Humans
Inflammatory Bowel Diseases
/ epidemiology
Italy
/ epidemiology
Male
Outpatients
/ psychology
Pandemics
Pneumonia, Viral
/ epidemiology
Surveys and Questionnaires
Telemedicine
COVID-19
Crohn disease
IBD
biologic agents
perception
survey
telemedicine
ulcerative colitis
Journal
Journal of medical Internet research
ISSN: 1438-8871
Titre abrégé: J Med Internet Res
Pays: Canada
ID NLM: 100959882
Informations de publication
Date de publication:
02 11 2020
02 11 2020
Historique:
received:
23
04
2020
accepted:
14
09
2020
revised:
07
07
2020
pubmed:
3
10
2020
medline:
13
11
2020
entrez:
2
10
2020
Statut:
epublish
Résumé
After the COVID-19 outbreak, the Italian Government stopped most regular health care activity. As a result, patients with inflammatory bowel disease (IBD) had limited access to outpatient clinics and hospitals. This study aimed to analyze the perception of the COVID-19 emergency among patients with IBD during the early weeks of the lockdown. We invited adult patients with IBD from the University of Salerno (Campania, South Italy) and the University of Padua (Veneto, North Italy) by email to answer an ad hoc anonymous survey about COVID-19. We also collected data on demographic and disease characteristics. In total, 167 patients with IBD from Padua and 83 patients from Salerno answered the survey (age: mean 39.7 years, SD 13.9 years; female: n=116, 46.4%). We found that patients with IBD were particularly worried about the COVID-19 pandemic (enough: 77/250, 30.8%; much/very much: 140/250, 56.0%), as they felt more vulnerable to COVID-19 due to their condition (enough: 70/250, 28.0%; much/very much: 109/250, 43.6%). Patients with IBD from the red zone of Veneto were more worried than patients from Campania (P=.001), and men felt more susceptible to the virus than women (P=.05). Additionally, remote medicine was appreciated more by younger patients than older patients (P=.04). The results of our survey demonstrate that the lockdown had a significant impact on the psychological aspects of patients with IBD and suggest the need for increasing communication with patients with IBD (eg, through telemedicine) to ensure patients receive adequate health care, correct information, and proper psychological support.
Sections du résumé
BACKGROUND
After the COVID-19 outbreak, the Italian Government stopped most regular health care activity. As a result, patients with inflammatory bowel disease (IBD) had limited access to outpatient clinics and hospitals.
OBJECTIVE
This study aimed to analyze the perception of the COVID-19 emergency among patients with IBD during the early weeks of the lockdown.
METHODS
We invited adult patients with IBD from the University of Salerno (Campania, South Italy) and the University of Padua (Veneto, North Italy) by email to answer an ad hoc anonymous survey about COVID-19. We also collected data on demographic and disease characteristics.
RESULTS
In total, 167 patients with IBD from Padua and 83 patients from Salerno answered the survey (age: mean 39.7 years, SD 13.9 years; female: n=116, 46.4%). We found that patients with IBD were particularly worried about the COVID-19 pandemic (enough: 77/250, 30.8%; much/very much: 140/250, 56.0%), as they felt more vulnerable to COVID-19 due to their condition (enough: 70/250, 28.0%; much/very much: 109/250, 43.6%). Patients with IBD from the red zone of Veneto were more worried than patients from Campania (P=.001), and men felt more susceptible to the virus than women (P=.05). Additionally, remote medicine was appreciated more by younger patients than older patients (P=.04).
CONCLUSIONS
The results of our survey demonstrate that the lockdown had a significant impact on the psychological aspects of patients with IBD and suggest the need for increasing communication with patients with IBD (eg, through telemedicine) to ensure patients receive adequate health care, correct information, and proper psychological support.
Identifiants
pubmed: 33006945
pii: v22i11e19574
doi: 10.2196/19574
pmc: PMC7654503
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e19574Informations de copyright
©Fabiana Zingone, Monica Siniscalchi, Edoardo Vincenzo Savarino, Brigida Barberio, Linda Cingolani, Renata D'Incà, Francesca Romana De Filippo, Silvia Camera, Carolina Ciacci. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 02.11.2020.
Références
Gastroenterology. 2020 Jun;158(8):2302-2304
pubmed: 32305331
Clin Gastroenterol Hepatol. 2020 Jun;18(7):1409-1411
pubmed: 32197957
J Clin Med. 2020 Jun 26;9(6):
pubmed: 32604895
J Gastroenterol Hepatol. 2019 Jun;34(6):996-1003
pubmed: 30562421
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Inflamm Bowel Dis. 2019 Jan 10;25(2):369-376
pubmed: 30020478
BMC Gastroenterol. 2017 Apr 14;17(1):52
pubmed: 28407755
Sci Rep. 2020 Jan 16;10(1):507
pubmed: 31949257
Am J Gastroenterol. 2013 Aug;108(8):1268-76
pubmed: 23649185
J Med Internet Res. 2004 Sep 29;6(3):e34
pubmed: 15471760
Dig Liver Dis. 2020 Oct;52(10):1071-1075
pubmed: 32425731
Gut. 2020 Jul;69(7):1213-1217
pubmed: 32354990
Front Immunol. 2020 May 27;11:1170
pubmed: 32574266
J Crohns Colitis. 2020 May 19;:
pubmed: 32426800
Am J Gastroenterol. 2016 Dec;111(12):1806-1815
pubmed: 27670599
J Med Internet Res. 2019 Mar 14;21(3):e10672
pubmed: 30869647
Pak J Med Sci. 2020 May;36(COVID19-S4):S90-S94
pubmed: 32582321
Ann Intern Med. 2020 Jul 21;173(2):157-160
pubmed: 32196071
Lancet. 2020 Feb 15;395(10223):470-473
pubmed: 31986257
Neurogastroenterol Motil. 2019 Mar;31(3):e13531
pubmed: 30628137
Ann Gastroenterol. 2019 May-Jun;32(3):247-256
pubmed: 31040621
Gastroenterol Res Pract. 2019 Aug 21;2019:5354320
pubmed: 31531015
Am J Gastroenterol. 2017 Feb;112(2):241-258
pubmed: 28071656
Lancet Gastroenterol Hepatol. 2020 Jun;5(6):525
pubmed: 32220656
Inflamm Bowel Dis. 2013 Oct;19(11):2380-6
pubmed: 23942564
United European Gastroenterol J. 2020 Jul;8(6):741-742
pubmed: 32423309
Clin Gastroenterol Hepatol. 2020 Sep;18(10):2179-2191.e6
pubmed: 31945470
J Travel Med. 2020 May 18;27(3):
pubmed: 32125413
Res Social Adm Pharm. 2016 Jan-Feb;12(1):141-148
pubmed: 26329534
Exp Brain Res. 2019 Jun;237(6):1563-1573
pubmed: 30927043
Nat Rev Gastroenterol Hepatol. 2020 May;17(5):253-255
pubmed: 32214232
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632
Dig Dis Sci. 2004 Mar;49(3):492-7
pubmed: 15139504